Status:
UNKNOWN
An Integrative Approach for Idiopathic Granulomatous Mastitis.
Lead Sponsor:
Medipol University
Conditions:
Idiopathic Granulomatous Mastitis
Eligibility:
FEMALE
25-45 years
Brief Summary
Collaboration is established between Turkish Holistic \& Integrative Medicine Association and Traditional \& Complementary Medicine Society of Istanbul Medipol University. Study is carried out on idi...
Eligibility Criteria
Inclusion
- IGM patients, either ones newly diagnosed or had previously received different types of treatments, currently refusing conventional treatments with immunosuppressives etc, or/and surgical management, and now und
Exclusion
- Patients currently using any conventional treatment, and/or contraindication to hirudotherapy and cupping.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04096300
Start Date
June 1 2019
End Date
September 1 2019
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medipol University
Beykoz, Istanbul, Turkey (Türkiye), 34810